Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 18Other hematologic neoplasm 14Plasma cell 12Thoracic 10Head & Neck 6Gastrointestinal 6Breast 6Genitourinary 5Myeloid 4Dermatologic 4Tumor-Agnostic 3Gynecologic 3CNS 3Other solid neoplasm 2Other 2Sarcoma 1Other neoplasm 1Endocrine 1

Conditions

Pituitary Neoplasms 1Headache 1Acromegaly 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Acetaminophen × Endocrine × Clear all
NCT04529356 2020-08-27

The TMS Treatment for Postoperative Headache in GH Tumor

Huashan Hospital

Phase NA Unknown
200 enrolled
Endocrine

Acromegaly, Headache, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡